A
1.17
0.00 (0.00%)
| 前收盘价格 | 1.17 |
| 收盘价格 | 1.09 |
| 成交量 | 238,707 |
| 平均成交量 (3个月) | 686,335 |
| 市值 | 58,285,184 |
| 价格/销量 (P/S) | 0.800 |
| 股市价格/股市净资产 (P/B) | 6.45 |
| 52周波幅 | |
| 利润日期 | 12 May 2025 - 16 May 2025 |
| 营业毛利率 | -59.44% |
| 营业利益率 (TTM) | -79.73% |
| 稀释每股收益 (EPS TTM) | -0.960 |
| 季度收入增长率 (YOY) | -9.30% |
| 总债务/股东权益 (D/E MRQ) | 1,107.91% |
| 流动比率 (MRQ) | 0.610 |
| 营业现金流 (OCF TTM) | -30.49 M |
| 杠杆自由现金流 (LFCF TTM) | -15.14 M |
| 资产报酬率 (ROA TTM) | -17.49% |
| 股东权益报酬率 (ROE TTM) | -354.27% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看涨 | 混合的 | |
| 股票 | Akoya BioSciences, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
-1.6
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -3.5 |
| 技术振荡指标 | 0.0 |
| 平均 | -1.57 |
|
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler® (formerly CODEX) and PhenoImager® (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Value |
| 内部持股比例 | 72.58% |
| 机构持股比例 | 69.80% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Peddock Capital Advisors, Llc | 30 Sep 2024 | 234,720 |
| Osterweis Capital Management Inc | 30 Sep 2024 | 126,131 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合